PHILADELPHIA, PA — Cabaletta Bio, Inc. (Nasdaq: CABA) announced that the Company will participate in three upcoming investor conferences in November:
- Guggenheim 5th Annual Inflammation, Neurology, & Immunology Conference: Steven Nichtberger, M.D., Chief Executive Officer, will participate in a fireside chat on Monday, November 6, 2023 at 9:50 a.m. ET in New York, NY. Members of management will also be available for one-on-one meetings.
- Stifel 2023 Healthcare Conference: Gwendolyn Binder, Ph.D., President of Science and Technology, will participate in a fireside chat on Tuesday, November 14, 2023, at 4:45 p.m. ET in New York, NY. Members of management will also be available for one-on-one meetings.
- 6th Annual Evercore ISI HealthCONx Conference: Steven Nichtberger, M.D., Chief Executive Officer, will participate in a fireside chat on Wednesday, November 29, 2023, at 8:20 a.m. ET in Miami, FL. Members of management will also be available for one-on-one meetings.
A live webcast of the presentations will be available on the News and Events section of the Company’s website at www.cabalettabio.com. Replays will be available on the website for 30 days.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.